English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

In vitro pharmacokinetic studies were conducted on enantiomer pairs of twelve valinate or tert -leucinate indole and indazole-3-carboxamide synthetic cannabinoid receptor agonists (SCRAs) detected on the illicit drug market to investigate their physicochemical parameters and structure-metabolism relationships (SMRs). Experimentally derived Log D 7.4 ranged from 2.81 (AB-FUBINACA) to 4.95 (MDMB-4en-PINACA) and all SCRAs tested were highly protein bound, ranging from 88.9 ± 0.49% (( R )-4F-MDMB-BINACA) to 99.5 ± 0.08% (( S )-MDMB-FUBINACA). Most tested SCRAs were cleared rapidly in vitro in pooled human liver microsomes (pHLM) and pooled cryopreserved human hepatocytes (pHHeps). Intrinsic clearance (CL int ) ranged from 13.7 ± 4.06 (( R )-AB-FUBINACA) to 2944 ± 95.9 mL min -1 kg -1 (( S )-AMB-FUBINACA) in pHLM, and from 110 ± 34.5 (( S )-AB-FUBINACA) to 3216 ± 607 mL min -1 kg -1 (( S )-AMB-FUBINACA) in pHHeps. Predicted Human in vivo hepatic clearance (CL H ) ranged from 0.34 ± 0.09 (( S )-AB-FUBINACA) to 17.79 ± 0.20 mL min -1 kg -1 (( S )-5F-AMB-PINACA) in pHLM and 1.39 ± 0.27 (( S )-MDMB-FUBINACA) to 18.25 ± 0.12 mL min -1 kg -1 (( S )-5F-AMB-PINACA) in pHHeps. Valinate and tert -leucinate indole and indazole-3-carboxamide SCRAs are often rapidly metabolised in vitro but are highly protein bound in vivo and therefore predicted in vivo CL H is much slower than CL int . This is likely to give rise to longer detection windows of these substances and their metabolites in urine, possibly as a result of accumulation of parent drug in lipid-rich tissues, with redistribution into the circulatory system and subsequent metabolism.

molecules/molecules online/molecules annual

A Systematic Study of the In Vitro Pharmacokinetics and Estimated Human In Vivo Clearance of Indole and Indazole-3-Carboxamide Synthetic Cannabinoid Receptor Agonists Detected on the Illicit Drug Market